| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | Chief Business Officer | Common Stock | 15.1K | $439K | $29.03 | Sep 20, 2024 | Direct |
| Edgewise Therapeutics, Inc. | Chief Business Officer | Restricted Stock Units | 23.1K | $437K | $18.91 | Aug 12, 2024 | Direct |
| Edgewise Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 103K | Sep 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| EWTX | Edgewise Therapeutics, Inc. | Sep 20, 2024 | 3 | -$1.14M | 4 | Sep 24, 2024 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | Aug 12, 2024 | 2 | $0 | 4 | Aug 14, 2024 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | May 1, 2024 | 3 | -$32.5K | 4 | May 3, 2024 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | Feb 7, 2024 | 9 | -$181K | 4 | Feb 9, 2024 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | Aug 17, 2023 | 1 | $0 | 4 | Aug 18, 2023 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | May 1, 2023 | 3 | -$15.6K | 4 | May 3, 2023 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | Aug 8, 2022 | 1 | $0 | 4 | Aug 10, 2022 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | May 1, 2022 | 1 | $0 | 4 | May 3, 2022 | Chief Business Officer |
| EWTX | Edgewise Therapeutics, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 19, 2021 | Chief Business Officer |